MEDCLOSE ARTERIAL CLOSURE DEVICE BEGINS MANUFACTURING OF UNITS IN PREPARATION OF SUBMITTING IDE APPLICATION

CPC of America reports that its subsidiary, Med Enclosure, has initiated the manufacturing and sterilization of its Rev "A" Internal Puncture Closure Device (MedClose) in preparation for launching a U.S. (IDE) clinical study. The MedClose is a proprietary catheter based system that uses Tisseel VH Fibrin Sealant to rapidly seal arterial puncture sites following angiography and angioplasty.

PR Newswire (http://media.prnewswire.com/en/jsp/myPRNJ.jsp?profileid=1101691&resourceid=2850765)